Terms: = Endocrine gland cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1
232 results:
1. [Clinical characteristics and prognosis of primary aldosteronism associated with subclinical Cushing syndrome].
Liao YY; Song Y; Hu JB; Yang SM; Zheng Y; Li QF
Zhonghua Nei Ke Za Zhi; 2024 Apr; 63(4):378-385. PubMed ID: 38561283
[No Abstract] [Full Text] [Related]
2. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract] [Full Text] [Related]
3. Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study.
Zhang N; He J; Maithel SK; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Lv Y; Zhang XF; Pawlik TM
Ann Surg Oncol; 2024 May; 31(5):2882-2891. PubMed ID: 38097878
[TBL] [Abstract] [Full Text] [Related]
4. Epigenetic inhibition of CTCF by hn1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
Pan Z; Lu X; Xu T; Chen J; Bao L; Li Y; Gong Y; Che Y; Zou X; Tan Z; Huang P; Ge M
Cancer Lett; 2024 Jan; 580():216496. PubMed ID: 37993084
[TBL] [Abstract] [Full Text] [Related]
5. Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells.
Casagrande N; Borghese C; Corona G; Aldinucci D; Altaf M; Sulaiman AAA; Isab AA; Ahmad S; Peedikakkal AMP
J Biol Inorg Chem; 2023 Dec; 28(8):751-766. PubMed ID: 37955736
[TBL] [Abstract] [Full Text] [Related]
6. Mechanisms of carboplatin- and paclitaxel-dependent induction of premature senescence and pro-cancerogenic conversion of normal peritoneal mesothelium and fibroblasts.
Rutecki S; Pakuła-Iwańska M; Leśniewska-Bocianowska A; Matuszewska J; Rychlewski D; Uruski P; Stryczyński Ł; Naumowicz E; Szubert S; Tykarski A; Mikuła-Pietrasik J; Książek K
J Pathol; 2024 Feb; 262(2):198-211. PubMed ID: 37941520
[TBL] [Abstract] [Full Text] [Related]
7. Single-cell sequencing reveals SATB2/notch1 signaling promotes the progression of malignancy of epithelial cells from papillary thyroid cancer.
Zhang W; Wang J; Huang D; Liu Z; Lu T; Cui C; Li Z
Mol Carcinog; 2024 Jan; 63(1):22-33. PubMed ID: 37877736
[TBL] [Abstract] [Full Text] [Related]
8.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
9. Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing notch1 degradation and downregulating key vasculogenic genes.
Qi J; Meng M; Liu J; Song X; Chen Y; Liu Y; Li X; Zhou Z; Huang X; Wang X; Zhou Q; Zhao Z
Biochem Pharmacol; 2023 Nov; 217():115833. PubMed ID: 37769714
[TBL] [Abstract] [Full Text] [Related]
10. Targeting Inhibition of Notch 1 Can Promote mTOR Signaling Pathway in Tumor-Related Macrophage to Regulate the Development of Ovarian cancer.
Guo C; Mo J; Liu X; Chen Y; Liang L; Li H; Yang L
Altern Ther Health Med; 2023 Nov; 29(8):364-369. PubMed ID: 37632963
[TBL] [Abstract] [Full Text] [Related]
11. Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells.
Wang H; Liu Y; Wang Y; Xu T; Xia G; Huang X
Cancer Med; 2023 Jul; 12(14):15277-15288. PubMed ID: 37409635
[TBL] [Abstract] [Full Text] [Related]
12. CD109 Promotes Drug Resistance in A2780 Ovarian cancer Cells by Regulating the STAT3-notch1 Signaling Axis.
Kim JS; Shin MJ; Lee SY; Kim DK; Choi KU; Suh DS; Kim D; Kim JH
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373457
[TBL] [Abstract] [Full Text] [Related]
13. PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway.
Wang D; Liu J; Chen Y; Jia L; Zhao K; He X
Environ Toxicol; 2024 Feb; 39(2):539-550. PubMed ID: 37347555
[TBL] [Abstract] [Full Text] [Related]
14. The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via notch1 pathway.
Yang L; Yang M; Cui C; Long X; Li Y; Dai W; Lang T; Zhou Q
Cell Signal; 2023 Jul; 107():110688. PubMed ID: 37105506
[TBL] [Abstract] [Full Text] [Related]
15. The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.
Liu M; Li N; Tang H; Chen L; Liu X; Wang Y; Lin Y; Luo Y; Wei S; Wen W; Chen M; Wang J; Zhang N; Chen J
Oncologist; 2023 Sep; 28(9):e723-e736. PubMed ID: 37086484
[TBL] [Abstract] [Full Text] [Related]
16. A
Jiang W; Ouyang X; Jiang C; Yin L; Yao Q; Pei X; Ji Z; Li M; Song S; Yang W; Huang S; Yang H; Shan B
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982170
[TBL] [Abstract] [Full Text] [Related]
17. NKX3.1 Expression and Molecular Characterization of Secretory Myoepithelial Carcinoma (SMCA): Advancing the Case for a Salivary Mucous Acinar Phenotype.
Patel S; Wald AI; Bastaki JM; Chiosea SI; Singhi AD; Seethala RR
Head Neck Pathol; 2023 Jun; 17(2):467-478. PubMed ID: 36746884
[TBL] [Abstract] [Full Text] [Related]
18. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
Chai H; Pan C; Zhang M; Huo H; Shan H; Wu J
BMC Cancer; 2023 Jan; 23(1):96. PubMed ID: 36707804
[TBL] [Abstract] [Full Text] [Related]
19. Notch signaling regulates vasculogenic mimicry and promotes cell morphogenesis and the epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
Benjakul N; Prakobphol N; Tangshewinsirikul C; Dulyaphat W; Svasti J; Charngkaew K; Kangsamaksin T
PLoS One; 2022; 17(12):e0279001. PubMed ID: 36548277
[TBL] [Abstract] [Full Text] [Related]
20. Thyroid carcinoma metastases to central nervous system and vertebrae.
Kleinschmidt-DeMasters B; Marshall C
Folia Neuropathol; 2022; 60(3):292-300. PubMed ID: 36382481
[TBL] [Abstract] [Full Text] [Related]
[Next]